Joint Formulary & PAD

Risperidone - Mania

You are here : Home > Formulary Search > Risperidone - Mania

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Blue
Formulations :
  • Oral solution
  • Tablets
Formulary Status :
Primary Care
ASPH
RSFT
SASH
SABP
Associated Icons :
Restrictions / Comments :
 

Status 2

Red
Formulations :
  • Oro-dispersible tablets
Formulary Status :
Primary Care
ASPH
RSFT
SASH
SABP
Associated Icons :
R
SPC
Restrictions / Comments :
Important

Only for use where the liquid formulation is unsuitable e.g. for supervised administration to ensure compliance.

Documentation

  • No records returned.

PAD Profile

ChemicalSubstance :
Risperidone
Indication :
Mania
Group Name :
Keywords :
Brand Names Include :
Important Information :

Initiation by a Mental Health specialist and stabilisation for a minimum of 1 month before any request to transfer prescribing responsibility.

Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
0
Traffic Light Entries :
2

Committee Recommendations (1)

03 Sep 25 - Surrey Heartlands Integrated Care System Area Prescribing Committee (APC)

The Surrey Heartlands Integrated Care System Area Prescribing Committee has agreed the length of prescribing of anti-psychotics by the specialist team at Surrey & Borders Partnership NHS Foundation Trust as:

Mental Health specialist initiation and prescribing for at least 1 month and until the patient is stabilised on treatment prior to transfer of care to primary care.

Where a stabilised patient requires a simple, non-complex and non-urgent dose adjustment, this can be managed in primary care on recommendation by the specialist team.

Other Indications

Below are listed other indications that Risperidone is used to treat.

Other Drugs

Below are listed other drugs that are used to treat Mania.